FI93443B - Menetelmä välituotteiden valmistamiseksi ja N-(2-hydroksietyyli)-2-hydroksimetyyli-3,4,5-trihydroksipiperidiinien syntetisoimiseksi - Google Patents

Menetelmä välituotteiden valmistamiseksi ja N-(2-hydroksietyyli)-2-hydroksimetyyli-3,4,5-trihydroksipiperidiinien syntetisoimiseksi

Info

Publication number
FI93443B
FI93443B FI905353A FI905353A FI93443B FI 93443 B FI93443 B FI 93443B FI 905353 A FI905353 A FI 905353A FI 905353 A FI905353 A FI 905353A FI 93443 B FI93443 B FI 93443B
Authority
FI
Finland
Prior art keywords
trihydroxypiperidines
hydroxymethyl
hydroxyethyl
preparation
intermediates
Prior art date
Application number
FI905353A
Other languages
English (en)
Swedish (sv)
Other versions
FI905353A0 (fi
FI93443C (fi
Inventor
Werner Hinsken
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI905353A0 publication Critical patent/FI905353A0/fi
Publication of FI93443B publication Critical patent/FI93443B/fi
Application granted granted Critical
Publication of FI93443C publication Critical patent/FI93443C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Enzymes And Modification Thereof (AREA)
FI905353A 1989-11-01 1990-10-30 Menetelmä välituotteiden valmistamiseksi ja N-(2-hydroksietyyli)-2-hydroksimetyyli-3,4,5-trihydroksipiperidiinien syntetisoimiseksi FI93443C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3936295 1989-11-01
DE3936295A DE3936295A1 (de) 1989-11-01 1989-11-01 Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine

Publications (3)

Publication Number Publication Date
FI905353A0 FI905353A0 (fi) 1990-10-30
FI93443B true FI93443B (fi) 1994-12-30
FI93443C FI93443C (fi) 1995-04-10

Family

ID=6392610

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905353A FI93443C (fi) 1989-11-01 1990-10-30 Menetelmä välituotteiden valmistamiseksi ja N-(2-hydroksietyyli)-2-hydroksimetyyli-3,4,5-trihydroksipiperidiinien syntetisoimiseksi

Country Status (16)

Country Link
US (1) US5071990A (fi)
EP (1) EP0425929B1 (fi)
JP (1) JP2858927B2 (fi)
KR (1) KR0169977B1 (fi)
AT (1) ATE131155T1 (fi)
CA (1) CA2028909C (fi)
DE (2) DE3936295A1 (fi)
DK (1) DK0425929T3 (fi)
ES (1) ES2082815T3 (fi)
FI (1) FI93443C (fi)
GR (1) GR3018765T3 (fi)
HU (1) HU205946B (fi)
IE (1) IE70059B1 (fi)
IL (1) IL96149A (fi)
PT (1) PT95737B (fi)
ZA (1) ZA908723B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
ES2537089T3 (es) * 2005-06-08 2015-06-02 Amicus Therapeutics, Inc. Purificación de imino- y amino-azúcares
US20060293508A1 (en) * 2005-06-08 2006-12-28 Michael Major Stabilization of triflated compounds
CN101228174A (zh) * 2005-06-08 2008-07-23 阿米库斯治疗学公司 晶体糖组合物及其制备方法
CN103980290B (zh) * 2013-12-06 2016-08-17 华东理工大学 具有杀虫活性的吗啉并环类化合物、及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759929A (en) * 1970-11-02 1973-09-18 Basf Ag Manufacture of {62 -hydroxy carbonyl compounds and/or {60 -unsaturated carbonyl compounds
DE2758025A1 (de) * 1977-12-24 1979-07-12 Bayer Ag Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
DE2922760A1 (de) * 1979-06-05 1980-12-11 Bayer Ag Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JPS6011902B2 (ja) * 1979-12-27 1985-03-28 日本新薬株式会社 モラノリンの誘導体
DE3024901A1 (de) * 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3049446A1 (de) * 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,5-didesoxy-1,5-imino-d-glucitol und dessen n-derivaten
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
JPS62267292A (ja) * 1986-05-14 1987-11-19 Nippon Shinyaku Co Ltd モラノリン誘導体の製法
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
DE3906463A1 (de) * 1989-03-01 1990-09-06 Bayer Ag Verfahren zur herstellung von n-hydroxyalkyl-substituierten derivaten von 3,4,5-trihydroxypiperidinen

Also Published As

Publication number Publication date
ZA908723B (en) 1991-08-28
KR910009661A (ko) 1991-06-28
FI905353A0 (fi) 1990-10-30
ES2082815T3 (es) 1996-04-01
EP0425929A1 (de) 1991-05-08
CA2028909A1 (en) 1991-05-02
FI93443C (fi) 1995-04-10
IL96149A0 (en) 1991-07-18
JPH03153666A (ja) 1991-07-01
IL96149A (en) 1995-05-26
US5071990A (en) 1991-12-10
GR3018765T3 (en) 1996-04-30
PT95737A (pt) 1991-09-13
HU205946B (en) 1992-07-28
JP2858927B2 (ja) 1999-02-17
CA2028909C (en) 2002-01-22
IE903924A1 (en) 1991-05-08
DE59009951D1 (de) 1996-01-18
ATE131155T1 (de) 1995-12-15
PT95737B (pt) 1997-11-28
DK0425929T3 (da) 1996-04-15
DE3936295A1 (de) 1991-05-02
KR0169977B1 (ko) 1999-02-18
HUT55404A (en) 1991-05-28
IE70059B1 (en) 1996-10-16
EP0425929B1 (de) 1995-12-06

Similar Documents

Publication Publication Date Title
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
ES2086341T3 (es) Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
BR9404830A (pt) Composto e processo para sua preparação
DK204686D0 (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
FI93443B (fi) Menetelmä välituotteiden valmistamiseksi ja N-(2-hydroksietyyli)-2-hydroksimetyyli-3,4,5-trihydroksipiperidiinien syntetisoimiseksi
FI875596A (fi) Foerfarande foer framstaellning av tienyletylaminer och aeven ditienyletylaminer.
BR9400016A (pt) Processo para preparação de compostos, e compostos
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ES2058723T3 (es) Bencilseleniobenzamidas de anilinas y benzilaminas.
ES2071723T3 (es) Bencilseleniobenzoamidas de aminopiridinas y picolilaminas.
ES2107562T3 (es) Amidas de acidos alfa-aril-alfa-hidroxi-beta-imidazolinil-propanoicos.
IT1182091B (it) Procedimento di sintesi industriale della n-(1'-allil-2'-pirrolidinil) metil)-2-metossi-4,5-azimmidobenzamide
DE58909745D1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BAYER HEALTHCARE AG

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT